The University of Southampton
University of Southampton Institutional Repository

Dragon 1 Protocol Manuscript: Training, accreditation, implementation and safety evaluation of portal and hepatic vein embolization (PVE/HVE) to accelerate future liver remnant (FLR) hypertrophy

Dragon 1 Protocol Manuscript: Training, accreditation, implementation and safety evaluation of portal and hepatic vein embolization (PVE/HVE) to accelerate future liver remnant (FLR) hypertrophy
Dragon 1 Protocol Manuscript: Training, accreditation, implementation and safety evaluation of portal and hepatic vein embolization (PVE/HVE) to accelerate future liver remnant (FLR) hypertrophy
Study purpose: the DRAGON 1 trial aims to assess training, implementation, safety and feasibility of combined portal- and hepatic-vein embolization (PVE/HVE) to accelerate future liver remnant (FLR) hypertrophy in patients with borderline resectable colorectal cancer liver metastases.Methods: the DRAGON 1 trial is a worldwide multicenter prospective single arm trial. The primary endpoint is a composite of the safety of PVE/HVE, 90-day mortality, and one year accrual monitoring of each participating center. Secondary endpoints include: feasibility of resection, the used PVE and HVE techniques, FLR-hypertrophy, liver function (subset of centers), overall survival, and disease-free survival. All complications after the PVE/HVE procedure are documented. Liver volumes will be measured at week 1 and if applicable at week 3 and 6 after PVE/HVE and follow-up visits will be held at 1, 3, 6, and 12 months after the resection.Results: not applicable.Conclusion: DRAGON 1 is a prospective trial to assess the safety and feasibility of PVE/HVE. Participating study centers will be trained, and procedures standardized using Work Instructions (WI) to prepare for the DRAGON 2 randomized controlled trial. Outcomes should reveal the accrual potential of centers, safety profile of combined PVE/HVE and the effect of FLR-hypertrophy induction by PVE/HVE in patients with CRLM and a small FLR.Trial registration: Clinicaltrials.gov: NCT04272931 (February 17, 2020). Toestingonline.nl: NL71535.068.19 (September 20, 2019).
0174-1551
1391–1398
Korenblik, R
ee2f7a0b-6688-4f43-b113-ef2cfeda0c0b
Olij, B
fdea6c84-d309-46ea-be88-6469d494643e
Aldrighetti, L A
a4b19d20-4a6e-4b98-9267-f76edcd689a0
Hilal, M Abu
62658d01-555b-4cd8-8a50-a2e1f8fa8816
Ahle, M
86fe9e9f-2f5b-452e-8e69-fc78caf3c2e0
Arslan, B
b08ec3cf-73e4-4e2e-86b6-14c4946fbdfd
van Baardewijk, L J
98568481-ddc9-4f10-ab1d-91f84f4b6e9e
Baclija, I
efd2580b-1d55-4d5c-a821-406c93266fdd
Bent, C
490b4d50-6e66-4726-97b5-331d536283ad
Bertrand, C L
8179c76c-2a53-4599-9c6c-9f4057a928d3
Björnsson, B
fe8fcaf2-bd24-497c-b00a-62f7fc34c2e4
de Boer, M T
3080b43a-ff09-4b43-9c39-c36787400852
de Boer, S W
21a649fe-286b-4b71-96a7-181fb8233d39
Bokkers, R P H
cbfe2010-2e9e-4368-9d9a-14c68a3e58d4
Rinkes, I H M Borel
9371dc4d-71a4-41ff-8beb-0a800783a46a
Breitenstein, S
d79ded3a-d610-477d-be2a-7043273c12de
Bruijnen, R C G
7def76eb-382f-4121-a812-cfbe80803013
Bruners, P
306e284c-44b9-4cb3-a51e-13d426e81242
Büchler, M W
b45fd663-626c-493f-888a-6097edd4a74e
Camacho, J C
31b3b765-abea-4bff-9f01-08fcf7583411
Cappelli, A
b97656a4-ddad-4d73-bf20-4802cc7203c6
Carling, U
8b27ef17-3667-474e-ad8b-ff45070f3fcd
Chan, B K Y
7313d487-e014-4561-a76c-f5d6017e29a5
Chang, D H
bd646a1a-cea2-463a-9cb3-df85d541c88c
Choi, J
9e1c1c71-69d4-4141-b0ca-66acf663b3a9
Font, J Codina
95ae02b6-6996-41d0-a4a0-5388b900942b
Crawford, M
8442a93d-670d-470c-a44b-65d7d9bc7080
Croagh, D
c65c6903-a099-4ab8-8172-d6bbf0cd039c
Cugat, E
b0be4b71-fcf0-4ce3-9226-8c956518aef9
Davis, R
382e1780-2660-4d9f-a5bf-e0526bbc5fbb
De Boo, D W
2d830032-519b-43e7-8286-2af4f8255eb2
De Cobelli, F
b2bee8c8-a5f5-4e5f-9c3c-4fb61259a958
De Wispelaere, J F
8ab06a73-a603-48d6-883a-239eac0d1645
van Delden, O M
cf3c1036-7f49-4a29-b42e-f43bd83a8c3a
Delle, M
56c37f9f-1f31-4329-99d9-3dcae8ff516c
Detry, O
1f2044be-5e7b-4b4c-be1f-028034cdbe50
Díaz-Nieto, R
d2ca8448-b3ea-4fe9-b432-2e23e3f160c3
Dili, A
30b68799-5782-403f-8af9-2dcabba45363
Erdmann, J I
f6e2e7af-8344-4b3a-ad1f-d3502622e935
Fisher, O
82f1e445-dc2f-49d2-bc4d-bc05283ccf35
Fondevila, C
aa6b2c0b-7c36-454b-a20a-c027e70e269f
Fretland, Å
e1edf2e5-06ee-43eb-b2b3-33ae0ca63ad3
Borobia, F Garcia
c6d473f6-1893-412b-965c-9fee3857886a
Gelabert, A
1422e65e-9b3c-4a89-abbb-cad472c5317e
Gérard, L
c7a6d49e-b83c-4e76-b36d-16507855b791
Giuliante, F
8873f642-ce98-4565-b89a-2008a90b442d
Gobardhan, P D
ac99a609-0669-43f3-a127-79e62b5d4242
Gómez, F
094d64a4-06d9-42e0-9266-6ee783489b9b
Grünberger, T
f1980fd9-0b0c-4500-8c23-614ebb40fe1d
Grünhagen, D J
442d868f-3e28-4a54-a484-e6f6eb793507
Guitart, J
d0149da1-3f23-4d0e-b0f8-19e5a9395793
Hagendoorn, J
a6eff1d2-4f0a-439f-9a96-5931e3b03e0f
Heil, J
8aadb7e3-bd29-468a-8901-7f33a8772e00
Heise, D
d7cddd3e-f46a-442b-be21-6e6144217f18
Herrero, E
463721cd-c910-407a-8c3c-85eaf6550a21
Hess, G F
9395db53-1c0a-4c58-89dd-34db9ad2eeff
Hoffmann, M H
8b496945-7380-4ba4-9fbc-8bccf717d40f
Iezzi, R
50f3a988-abf7-45e9-b1bc-a80c9088e331
Imani, F
5d970c19-0f6c-4f1f-adad-bfdc5ae39e0a
Nguyen, J
8b0794e7-223d-4092-92a4-f5076ea28af6
Jovine, E
f3200763-e6a9-41a7-b6b7-05e62823f0bb
Kalff, J C
0f519a21-5ac7-4d67-8b7c-f9ee0bd472c6
Kazemier, G
33b7bfcd-f883-499d-85ab-6e6af1872a47
Kingham, T P
431b10ba-90ad-4b99-95ee-19f3a0bf6906
Kleeff, J
285cba7f-b5ae-4d1e-b819-ffbfa9fc9bd1
Kollmar, O
4ae4d61c-17b2-4462-955b-7e4673fc01b0
Leclercq, W K G
ba3e0a7b-e6c3-49e8-9e4e-b86cd9c1626a
Ben, S Lopez
acd4bae9-57fa-430d-855a-3c9e86e19df7
Lucidi, V
ce983665-8649-4533-98b7-7ebeaef6174e
MacDonald, A
d1d8af35-db4d-40ca-a644-82c94018ce0c
Madoff, D C
038db1db-2e15-4530-962c-ab0e015c7c7d
Manekeller, S
0b557bb7-9aaa-4c9f-9a0b-7fed1a9fe51c
Martel, G
4fec7691-f834-4505-88e2-e9595b2ab6bc
Mehrabi, A
96cf8687-b927-4a42-8f66-8a13c36f67ed
Mehrzad, H
b9ba999f-2ecd-41c8-82fc-39463c1d6708
Meijerink, M R
87824d3d-998d-47a8-97c7-eff1f6e5d0eb
Menon, K
77ea4a0d-d5d8-47da-91df-6a5a07970042
Metrakos, P
175f6f12-a6bc-4de7-8466-a2a7a00630da
Meyer, C
58af247c-0c51-4872-bb9c-3384fbf8d3a2
Moelker, A
6870f830-cfdc-42f9-8671-9bdf76fe5f99
Modi, S
c37661d6-e480-48ae-963d-6eb8283494d0
Montanari, N
6611397f-4ed7-43e2-be29-b3047e5ab67c
Navines, J
4a51a381-a5f3-4856-b155-3e705d01bb6d
Neumann, U P
7ac1d499-f9e5-45ab-bcf0-d0449819b262
Peddu, P
5ff54267-27fc-4b25-a576-1b7815cd3fbe
Primrose, J N
d85f3b28-24c6-475f-955b-ec457a3f9185
Qu, X
8920a65d-1d4d-4ecb-8378-26aaadc8a2e9
Raptis, D
0a25766b-8a41-4ef4-b7be-36b506699aea
Ratti, F
5f2db521-ddb1-474e-b39e-27284f990098
Ridouani, F
e60db765-684d-4d7e-a51c-2b8f95684ecd
Rogan, C
169fb2e3-e2b9-470e-8a3f-d81ed97f3e6b
Ronellenfitsch, U
307dd0d3-2539-482f-90ca-a29118e681e1
Ryan, S
df133b98-ee8e-44e6-a4ea-3a829fe4d102
Sallemi, C
41b88202-661b-460a-a5d7-18d0b4d9edaa
Moragues, J Sampere
ff1ead23-3ca0-4bb8-8db2-85aef9baf804
Sandström, P
92e6b726-fafe-4e95-bd0c-670ba43053a2
Sarriá, L
eb9a872c-779f-49bb-b257-d10daa695c62
Schnitzbauer, A
38d21754-0a5e-4371-8a9f-35f027d41ce7
Serenari, M
24eb6801-3388-4a74-b5e6-2a955097641e
Serrablo, A
696940e7-6e70-4e33-b18f-1cc9d0b31e15
Smits, M L J
0560fd6b-c9c5-44a9-9fca-a4c17fe23447
Sparrelid, E
32a4658b-318b-461d-98fc-a315f9b368b6
Spüntrup, E
5f803ada-94eb-40c4-8e2d-fe6861c2e12d
Stavrou, G A
90dd46fe-28aa-4e72-9541-b3ae897a87d5
Sutcliffe, R P
53a0327d-e30f-4bf9-a284-986a82268276
Tancredi, I
e4502a93-ec03-4df7-8514-05a984193660
Tasse, J C
c5cdfe2c-3e72-4092-953f-689bfd6e8970
Udupa, V
e818d404-ec01-4346-9dc4-f73d28102a61
Valenti, D
ecf048b4-42dd-4977-af3d-3f851135ba52
Fundora, Y
c2053865-1d40-45eb-ab53-28ca2324a619
Vogl, T J
8c71586e-d1c1-4991-9013-135c7351a20c
Wang, X
976221d1-3004-409c-8640-715bedfc5d15
White, S A
91022fb9-a3a1-43eb-8efd-b69e3f386ff2
Wohlgemuth, W A
3fff3dc7-69df-4d7c-947f-32c164a9e204
Yu, D
645d8a79-27b5-4cd7-b34c-2226883e2f15
Zijlstra, I A J
9bf87779-e218-47ec-854f-d19c266de1aa
Binkert, C A
fe6dbdad-1917-42a1-8c08-22582d1f6c96
Bemelmans, M H A
9b73c125-896c-4865-b813-d26d69cecec3
van der Leij, C
243a7c92-4604-4e69-bb89-e324b0b3096f
Schadde, E
863001da-0fa7-4d9a-9aa3-b86cabefe7db
van Dam, R M
d1204c34-6a22-4ebf-bfd5-4efa4a639dcb
Korenblik, R
ee2f7a0b-6688-4f43-b113-ef2cfeda0c0b
Olij, B
fdea6c84-d309-46ea-be88-6469d494643e
Aldrighetti, L A
a4b19d20-4a6e-4b98-9267-f76edcd689a0
Hilal, M Abu
62658d01-555b-4cd8-8a50-a2e1f8fa8816
Ahle, M
86fe9e9f-2f5b-452e-8e69-fc78caf3c2e0
Arslan, B
b08ec3cf-73e4-4e2e-86b6-14c4946fbdfd
van Baardewijk, L J
98568481-ddc9-4f10-ab1d-91f84f4b6e9e
Baclija, I
efd2580b-1d55-4d5c-a821-406c93266fdd
Bent, C
490b4d50-6e66-4726-97b5-331d536283ad
Bertrand, C L
8179c76c-2a53-4599-9c6c-9f4057a928d3
Björnsson, B
fe8fcaf2-bd24-497c-b00a-62f7fc34c2e4
de Boer, M T
3080b43a-ff09-4b43-9c39-c36787400852
de Boer, S W
21a649fe-286b-4b71-96a7-181fb8233d39
Bokkers, R P H
cbfe2010-2e9e-4368-9d9a-14c68a3e58d4
Rinkes, I H M Borel
9371dc4d-71a4-41ff-8beb-0a800783a46a
Breitenstein, S
d79ded3a-d610-477d-be2a-7043273c12de
Bruijnen, R C G
7def76eb-382f-4121-a812-cfbe80803013
Bruners, P
306e284c-44b9-4cb3-a51e-13d426e81242
Büchler, M W
b45fd663-626c-493f-888a-6097edd4a74e
Camacho, J C
31b3b765-abea-4bff-9f01-08fcf7583411
Cappelli, A
b97656a4-ddad-4d73-bf20-4802cc7203c6
Carling, U
8b27ef17-3667-474e-ad8b-ff45070f3fcd
Chan, B K Y
7313d487-e014-4561-a76c-f5d6017e29a5
Chang, D H
bd646a1a-cea2-463a-9cb3-df85d541c88c
Choi, J
9e1c1c71-69d4-4141-b0ca-66acf663b3a9
Font, J Codina
95ae02b6-6996-41d0-a4a0-5388b900942b
Crawford, M
8442a93d-670d-470c-a44b-65d7d9bc7080
Croagh, D
c65c6903-a099-4ab8-8172-d6bbf0cd039c
Cugat, E
b0be4b71-fcf0-4ce3-9226-8c956518aef9
Davis, R
382e1780-2660-4d9f-a5bf-e0526bbc5fbb
De Boo, D W
2d830032-519b-43e7-8286-2af4f8255eb2
De Cobelli, F
b2bee8c8-a5f5-4e5f-9c3c-4fb61259a958
De Wispelaere, J F
8ab06a73-a603-48d6-883a-239eac0d1645
van Delden, O M
cf3c1036-7f49-4a29-b42e-f43bd83a8c3a
Delle, M
56c37f9f-1f31-4329-99d9-3dcae8ff516c
Detry, O
1f2044be-5e7b-4b4c-be1f-028034cdbe50
Díaz-Nieto, R
d2ca8448-b3ea-4fe9-b432-2e23e3f160c3
Dili, A
30b68799-5782-403f-8af9-2dcabba45363
Erdmann, J I
f6e2e7af-8344-4b3a-ad1f-d3502622e935
Fisher, O
82f1e445-dc2f-49d2-bc4d-bc05283ccf35
Fondevila, C
aa6b2c0b-7c36-454b-a20a-c027e70e269f
Fretland, Å
e1edf2e5-06ee-43eb-b2b3-33ae0ca63ad3
Borobia, F Garcia
c6d473f6-1893-412b-965c-9fee3857886a
Gelabert, A
1422e65e-9b3c-4a89-abbb-cad472c5317e
Gérard, L
c7a6d49e-b83c-4e76-b36d-16507855b791
Giuliante, F
8873f642-ce98-4565-b89a-2008a90b442d
Gobardhan, P D
ac99a609-0669-43f3-a127-79e62b5d4242
Gómez, F
094d64a4-06d9-42e0-9266-6ee783489b9b
Grünberger, T
f1980fd9-0b0c-4500-8c23-614ebb40fe1d
Grünhagen, D J
442d868f-3e28-4a54-a484-e6f6eb793507
Guitart, J
d0149da1-3f23-4d0e-b0f8-19e5a9395793
Hagendoorn, J
a6eff1d2-4f0a-439f-9a96-5931e3b03e0f
Heil, J
8aadb7e3-bd29-468a-8901-7f33a8772e00
Heise, D
d7cddd3e-f46a-442b-be21-6e6144217f18
Herrero, E
463721cd-c910-407a-8c3c-85eaf6550a21
Hess, G F
9395db53-1c0a-4c58-89dd-34db9ad2eeff
Hoffmann, M H
8b496945-7380-4ba4-9fbc-8bccf717d40f
Iezzi, R
50f3a988-abf7-45e9-b1bc-a80c9088e331
Imani, F
5d970c19-0f6c-4f1f-adad-bfdc5ae39e0a
Nguyen, J
8b0794e7-223d-4092-92a4-f5076ea28af6
Jovine, E
f3200763-e6a9-41a7-b6b7-05e62823f0bb
Kalff, J C
0f519a21-5ac7-4d67-8b7c-f9ee0bd472c6
Kazemier, G
33b7bfcd-f883-499d-85ab-6e6af1872a47
Kingham, T P
431b10ba-90ad-4b99-95ee-19f3a0bf6906
Kleeff, J
285cba7f-b5ae-4d1e-b819-ffbfa9fc9bd1
Kollmar, O
4ae4d61c-17b2-4462-955b-7e4673fc01b0
Leclercq, W K G
ba3e0a7b-e6c3-49e8-9e4e-b86cd9c1626a
Ben, S Lopez
acd4bae9-57fa-430d-855a-3c9e86e19df7
Lucidi, V
ce983665-8649-4533-98b7-7ebeaef6174e
MacDonald, A
d1d8af35-db4d-40ca-a644-82c94018ce0c
Madoff, D C
038db1db-2e15-4530-962c-ab0e015c7c7d
Manekeller, S
0b557bb7-9aaa-4c9f-9a0b-7fed1a9fe51c
Martel, G
4fec7691-f834-4505-88e2-e9595b2ab6bc
Mehrabi, A
96cf8687-b927-4a42-8f66-8a13c36f67ed
Mehrzad, H
b9ba999f-2ecd-41c8-82fc-39463c1d6708
Meijerink, M R
87824d3d-998d-47a8-97c7-eff1f6e5d0eb
Menon, K
77ea4a0d-d5d8-47da-91df-6a5a07970042
Metrakos, P
175f6f12-a6bc-4de7-8466-a2a7a00630da
Meyer, C
58af247c-0c51-4872-bb9c-3384fbf8d3a2
Moelker, A
6870f830-cfdc-42f9-8671-9bdf76fe5f99
Modi, S
c37661d6-e480-48ae-963d-6eb8283494d0
Montanari, N
6611397f-4ed7-43e2-be29-b3047e5ab67c
Navines, J
4a51a381-a5f3-4856-b155-3e705d01bb6d
Neumann, U P
7ac1d499-f9e5-45ab-bcf0-d0449819b262
Peddu, P
5ff54267-27fc-4b25-a576-1b7815cd3fbe
Primrose, J N
d85f3b28-24c6-475f-955b-ec457a3f9185
Qu, X
8920a65d-1d4d-4ecb-8378-26aaadc8a2e9
Raptis, D
0a25766b-8a41-4ef4-b7be-36b506699aea
Ratti, F
5f2db521-ddb1-474e-b39e-27284f990098
Ridouani, F
e60db765-684d-4d7e-a51c-2b8f95684ecd
Rogan, C
169fb2e3-e2b9-470e-8a3f-d81ed97f3e6b
Ronellenfitsch, U
307dd0d3-2539-482f-90ca-a29118e681e1
Ryan, S
df133b98-ee8e-44e6-a4ea-3a829fe4d102
Sallemi, C
41b88202-661b-460a-a5d7-18d0b4d9edaa
Moragues, J Sampere
ff1ead23-3ca0-4bb8-8db2-85aef9baf804
Sandström, P
92e6b726-fafe-4e95-bd0c-670ba43053a2
Sarriá, L
eb9a872c-779f-49bb-b257-d10daa695c62
Schnitzbauer, A
38d21754-0a5e-4371-8a9f-35f027d41ce7
Serenari, M
24eb6801-3388-4a74-b5e6-2a955097641e
Serrablo, A
696940e7-6e70-4e33-b18f-1cc9d0b31e15
Smits, M L J
0560fd6b-c9c5-44a9-9fca-a4c17fe23447
Sparrelid, E
32a4658b-318b-461d-98fc-a315f9b368b6
Spüntrup, E
5f803ada-94eb-40c4-8e2d-fe6861c2e12d
Stavrou, G A
90dd46fe-28aa-4e72-9541-b3ae897a87d5
Sutcliffe, R P
53a0327d-e30f-4bf9-a284-986a82268276
Tancredi, I
e4502a93-ec03-4df7-8514-05a984193660
Tasse, J C
c5cdfe2c-3e72-4092-953f-689bfd6e8970
Udupa, V
e818d404-ec01-4346-9dc4-f73d28102a61
Valenti, D
ecf048b4-42dd-4977-af3d-3f851135ba52
Fundora, Y
c2053865-1d40-45eb-ab53-28ca2324a619
Vogl, T J
8c71586e-d1c1-4991-9013-135c7351a20c
Wang, X
976221d1-3004-409c-8640-715bedfc5d15
White, S A
91022fb9-a3a1-43eb-8efd-b69e3f386ff2
Wohlgemuth, W A
3fff3dc7-69df-4d7c-947f-32c164a9e204
Yu, D
645d8a79-27b5-4cd7-b34c-2226883e2f15
Zijlstra, I A J
9bf87779-e218-47ec-854f-d19c266de1aa
Binkert, C A
fe6dbdad-1917-42a1-8c08-22582d1f6c96
Bemelmans, M H A
9b73c125-896c-4865-b813-d26d69cecec3
van der Leij, C
243a7c92-4604-4e69-bb89-e324b0b3096f
Schadde, E
863001da-0fa7-4d9a-9aa3-b86cabefe7db
van Dam, R M
d1204c34-6a22-4ebf-bfd5-4efa4a639dcb

Korenblik, R, Olij, B, Aldrighetti, L A, Hilal, M Abu, Ahle, M, Arslan, B, van Baardewijk, L J, Baclija, I, Bent, C, Bertrand, C L, Björnsson, B, de Boer, M T, de Boer, S W, Bokkers, R P H, Rinkes, I H M Borel, Breitenstein, S, Bruijnen, R C G, Bruners, P, Büchler, M W, Camacho, J C, Cappelli, A, Carling, U, Chan, B K Y, Chang, D H, Choi, J, Font, J Codina, Crawford, M, Croagh, D, Cugat, E, Davis, R, De Boo, D W, De Cobelli, F, De Wispelaere, J F, van Delden, O M, Delle, M, Detry, O, Díaz-Nieto, R, Dili, A, Erdmann, J I, Fisher, O, Fondevila, C, Fretland, Å, Borobia, F Garcia, Gelabert, A, Gérard, L, Giuliante, F, Gobardhan, P D, Gómez, F, Grünberger, T, Grünhagen, D J, Guitart, J, Hagendoorn, J, Heil, J, Heise, D, Herrero, E, Hess, G F, Hoffmann, M H, Iezzi, R, Imani, F, Nguyen, J, Jovine, E, Kalff, J C, Kazemier, G, Kingham, T P, Kleeff, J, Kollmar, O, Leclercq, W K G, Ben, S Lopez, Lucidi, V, MacDonald, A, Madoff, D C, Manekeller, S, Martel, G, Mehrabi, A, Mehrzad, H, Meijerink, M R, Menon, K, Metrakos, P, Meyer, C, Moelker, A, Modi, S, Montanari, N, Navines, J, Neumann, U P, Peddu, P, Primrose, J N, Qu, X, Raptis, D, Ratti, F, Ridouani, F, Rogan, C, Ronellenfitsch, U, Ryan, S, Sallemi, C, Moragues, J Sampere, Sandström, P, Sarriá, L, Schnitzbauer, A, Serenari, M, Serrablo, A, Smits, M L J, Sparrelid, E, Spüntrup, E, Stavrou, G A, Sutcliffe, R P, Tancredi, I, Tasse, J C, Udupa, V, Valenti, D, Fundora, Y, Vogl, T J, Wang, X, White, S A, Wohlgemuth, W A, Yu, D, Zijlstra, I A J, Binkert, C A, Bemelmans, M H A, van der Leij, C, Schadde, E and van Dam, R M (2022) Dragon 1 Protocol Manuscript: Training, accreditation, implementation and safety evaluation of portal and hepatic vein embolization (PVE/HVE) to accelerate future liver remnant (FLR) hypertrophy. Cardiovascular and Interventional Radiology, 45 (9), 1391–1398. (doi:10.1007/s00270-022-03176-1).

Record type: Article

Abstract

Study purpose: the DRAGON 1 trial aims to assess training, implementation, safety and feasibility of combined portal- and hepatic-vein embolization (PVE/HVE) to accelerate future liver remnant (FLR) hypertrophy in patients with borderline resectable colorectal cancer liver metastases.Methods: the DRAGON 1 trial is a worldwide multicenter prospective single arm trial. The primary endpoint is a composite of the safety of PVE/HVE, 90-day mortality, and one year accrual monitoring of each participating center. Secondary endpoints include: feasibility of resection, the used PVE and HVE techniques, FLR-hypertrophy, liver function (subset of centers), overall survival, and disease-free survival. All complications after the PVE/HVE procedure are documented. Liver volumes will be measured at week 1 and if applicable at week 3 and 6 after PVE/HVE and follow-up visits will be held at 1, 3, 6, and 12 months after the resection.Results: not applicable.Conclusion: DRAGON 1 is a prospective trial to assess the safety and feasibility of PVE/HVE. Participating study centers will be trained, and procedures standardized using Work Instructions (WI) to prepare for the DRAGON 2 randomized controlled trial. Outcomes should reveal the accrual potential of centers, safety profile of combined PVE/HVE and the effect of FLR-hypertrophy induction by PVE/HVE in patients with CRLM and a small FLR.Trial registration: Clinicaltrials.gov: NCT04272931 (February 17, 2020). Toestingonline.nl: NL71535.068.19 (September 20, 2019).

Text
s00270-022-03176-1 - Version of Record
Available under License Creative Commons Attribution.
Download (343kB)

More information

Accepted/In Press date: 8 May 2022
Published date: 1 September 2022
Additional Information: Funding Information: The Dutch Cancer Society (KWF), Maastricht University Medical Center, NIHR, Guerbet, and Abbott Laboratories provided unrestricted financial support for monitoring, coordination and the infrastructure of this trial. All funders do not interfere with the initiation, coordination, analyzation, or publication of the results. Maastricht University is the sponsor of the DRAGON 1 trial. Publisher Copyright: © 2022, The Author(s).

Identifiers

Local EPrints ID: 469236
URI: http://eprints.soton.ac.uk/id/eprint/469236
ISSN: 0174-1551
PURE UUID: e380dcc4-009f-430a-ab4d-9ba89b5c497d
ORCID for J N Primrose: ORCID iD orcid.org/0000-0002-2069-7605

Catalogue record

Date deposited: 09 Sep 2022 16:47
Last modified: 17 Mar 2024 02:40

Export record

Altmetrics

Contributors

Author: R Korenblik
Author: B Olij
Author: L A Aldrighetti
Author: M Abu Hilal
Author: M Ahle
Author: B Arslan
Author: L J van Baardewijk
Author: I Baclija
Author: C Bent
Author: C L Bertrand
Author: B Björnsson
Author: M T de Boer
Author: S W de Boer
Author: R P H Bokkers
Author: I H M Borel Rinkes
Author: S Breitenstein
Author: R C G Bruijnen
Author: P Bruners
Author: M W Büchler
Author: J C Camacho
Author: A Cappelli
Author: U Carling
Author: B K Y Chan
Author: D H Chang
Author: J Choi
Author: J Codina Font
Author: M Crawford
Author: D Croagh
Author: E Cugat
Author: R Davis
Author: D W De Boo
Author: F De Cobelli
Author: J F De Wispelaere
Author: O M van Delden
Author: M Delle
Author: O Detry
Author: R Díaz-Nieto
Author: A Dili
Author: J I Erdmann
Author: O Fisher
Author: C Fondevila
Author: Å Fretland
Author: F Garcia Borobia
Author: A Gelabert
Author: L Gérard
Author: F Giuliante
Author: P D Gobardhan
Author: F Gómez
Author: T Grünberger
Author: D J Grünhagen
Author: J Guitart
Author: J Hagendoorn
Author: J Heil
Author: D Heise
Author: E Herrero
Author: G F Hess
Author: M H Hoffmann
Author: R Iezzi
Author: F Imani
Author: J Nguyen
Author: E Jovine
Author: J C Kalff
Author: G Kazemier
Author: T P Kingham
Author: J Kleeff
Author: O Kollmar
Author: W K G Leclercq
Author: S Lopez Ben
Author: V Lucidi
Author: A MacDonald
Author: D C Madoff
Author: S Manekeller
Author: G Martel
Author: A Mehrabi
Author: H Mehrzad
Author: M R Meijerink
Author: K Menon
Author: P Metrakos
Author: C Meyer
Author: A Moelker
Author: S Modi
Author: N Montanari
Author: J Navines
Author: U P Neumann
Author: P Peddu
Author: J N Primrose ORCID iD
Author: X Qu
Author: D Raptis
Author: F Ratti
Author: F Ridouani
Author: C Rogan
Author: U Ronellenfitsch
Author: S Ryan
Author: C Sallemi
Author: J Sampere Moragues
Author: P Sandström
Author: L Sarriá
Author: A Schnitzbauer
Author: M Serenari
Author: A Serrablo
Author: M L J Smits
Author: E Sparrelid
Author: E Spüntrup
Author: G A Stavrou
Author: R P Sutcliffe
Author: I Tancredi
Author: J C Tasse
Author: V Udupa
Author: D Valenti
Author: Y Fundora
Author: T J Vogl
Author: X Wang
Author: S A White
Author: W A Wohlgemuth
Author: D Yu
Author: I A J Zijlstra
Author: C A Binkert
Author: M H A Bemelmans
Author: C van der Leij
Author: E Schadde
Author: R M van Dam

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×